Parkwood LLC Monte Rosa Therapeutics, Inc. Transaction History
Parkwood LLC
- $880 Million
- Q4 2024
A detailed history of Parkwood LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Parkwood LLC holds 323,000 shares of GLUE stock, worth $2.17 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
323,000
Previous 426,620
24.29%
Holding current value
$2.17 Million
Previous $2.26 Million
0.84%
% of portfolio
0.25%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding GLUE
# of Institutions
96Shares Held
51MCall Options Held
141KPut Options Held
31.2K-
Nea Management Company, LLC Timonium, MD7.69MShares$51.7 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.12MShares$47.8 Million0.01% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$38 Million58.01% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$33 Million0.28% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.35MShares$29.2 Million0.44% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $314M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...